Results for tag: "Sicca Syndrome Drug"

The Sicca Syndrome Drug market is a subset of the Immune Disorders Drugs market. It is composed of drugs used to treat Sicca Syndrome, a chronic autoimmune disorder characterized by dry eyes and dry mouth. These drugs are used to reduce inflammation and improve the symptoms of the disorder. Commonly prescribed drugs include corticosteroids, immunosuppressants, and biologics. Additionally, non-pharmacological treatments such as artificial tears and saliva substitutes are also used to manage the symptoms of Sicca Syndrome. The Sicca Syndrome Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more